Skip to main content

NATIONAL HEALTHCARE CORP

Data quality: 100%
NHC
NYSE Services Health Services
$170.85
▼ $5.96 (-3.37%)
Mkt Cap: 2.76 B
Price
$177.22
Mkt Cap
2.76 B
Day Range
52-Week Range
Volume
Open —
50D / 200D Avg
50D / 200D Avg

Quick Summary

Key Takeaways

Revenue grew 9.02% annually over 5 years — modest growth
Earnings grew 17.75% over the past year
ROE of 11.57% — decent returns on equity
Debt/Equity of 0.07 — conservative balance sheet
Generating 148.63 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.07%

Growth

Revenue Growth (5Y)
9.02%
Above sector avg (3.76%)
Revenue (1Y)16.09%
Earnings (1Y)17.75%
FCF Growth (3Y)33.57%

Quality

Return on Equity
11.57%
Above sector avg (-15.74%)
ROIC7.50%
Net Margin7.91%
Op. Margin8.46%

Safety

Debt / Equity
0.07
Below sector avg (0.39)
Current Ratio1.75
Interest Coverage20.15

Valuation

PE (TTM)
23.03
Above sector avg (-1.17)
P/B Ratio2.63
EV/EBITDA15.62
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E 23.0 -1.2
P/B 2.6 1.4
ROE % 11.6 -15.7
Net Margin % 7.9 -18.3
Rev Growth 5Y % 9.0 3.8
D/E 0.1 0.4

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 1 quarter
Quarter Est. EPS Actual EPS Surprise
Q22021 N/A $6.80

ETFs Holding This Stock

SOVF logo SOVF Sovereign's Capital Flourish Fund
1.35% weight
BOGIX BOGIX
1.00% weight
AFSM logo AFSM First Trust Active Factor Small Cap ETF
0.71% weight
FYLD FYLD
0.70% weight
SDVY logo SDVY First Trust SMID Cap Rising Dividend Achievers ETF
0.49% weight
SDVD SDVD
0.48% weight
TASVX TASVX
0.46% weight
TSVQX TSVQX
0.46% weight
TSVAX TSVAX
0.46% weight
TSVRX TSVRX
0.46% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y) 16.09% Revenue Growth (3Y) 15.31%
Earnings Growth (1Y) 17.75% Earnings Growth (3Y) 34.04%
Revenue Growth (5Y) 9.02% Earnings Growth (5Y) -3.53%
Profitability
Revenue (TTM) 1.52 B Net Income (TTM) 120.02 M
ROE 11.57% ROA 7.66%
Gross Margin N/A Operating Margin 8.46%
Net Margin 7.91% Free Cash Flow (TTM) 148.63 M
ROIC 7.50% FCF Growth (3Y) 33.57%
Safety
Debt / Equity 0.07 Current Ratio 1.75
Interest Coverage 20.15 Asset Turnover 0.97
Working Capital 211.16 M Tangible Book Value 862.64 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 23.03 Forward P/E N/A
P/B Ratio 2.63 P/S Ratio 1.82
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 15.62 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 5.38%
Market Cap 2.76 B Enterprise Value 2.71 B
Per Share
EPS (Diluted TTM) 7.67 Revenue / Share 97.30
FCF / Share 9.53 OCF / Share 11.86
EPS CAGR (1Y) 17.46% EPS CAGR (5Y) -3.89%
EPS CAGR (10Y) 9.75%
Efficiency
CapEx / Revenue 2.40% FCF Conversion 123.84%
SBC-Adj. FCF 144.04 M Growth Momentum 7.07

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.52 B 1.31 B 1.14 B 1.09 B 1.07 B
Net Income 120.02 M 101.93 M 66.80 M 22.45 M 138.59 M
EPS (Diluted) 7.67 6.53 4.34 1.45 8.99
Gross Profit
Operating Income 128.35 M 85.76 M 57.13 M 31.90 M 50.93 M
EBITDA
R&D Expenses
SG&A Expenses
D&A 44.92 M 41.99 M 42.03 M 40.49 M 40.67 M
Interest Expense 6.37 M 4.14 M 324,000.0 563,000.0 845,000.0
Income Tax 39.83 M 34.32 M 23.45 M 7.25 M 10.95 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.53 B 1.52 B 1.31 B 1.28 B 1.40 B
Total Liabilities 451.90 M 541.27 M 400.32 M 397.94 M 494.94 M
Shareholders' Equity 1.07 B 980.16 M 908.75 M 874.28 M 903.00 M
Total Debt 40.00 M 137.00 M
Cash & Equivalents 92.83 M 76.12 M 107.08 M 58.67 M 107.61 M
Current Assets 461.82 M 424.41 M 406.24 M 353.93 M 426.64 M
Current Liabilities 253.63 M 234.80 M 214.48 M 197.89 M 263.20 M